OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference
Single Domain Antibody Platform Market to Reach US$ 86 Million by 2034, Expanding at a CAGR of 10.1% | Fact.MR Report [Yahoo! Finance]
OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates [Yahoo! Finance]
OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.
OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.